Cell Therapy
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
132
NCT05050006
ITIL-168 in Advanced Melanoma
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 7, 2021
Completion: Feb 27, 2023
NCT05397093
ITIL-306 in Advanced Solid Tumors
Phase: Phase 1
Start: Aug 24, 2022
Completion: Nov 30, 2039
NCT05393635
ITIL-168 in Advanced Solid Tumors
Start: Aug 31, 2022
Completion: Dec 8, 2022
NCT07159828
A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors
Role: Collaborator
Start: Sep 15, 2025
Completion: May 15, 2027
Loading map...